These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 33728324)
1. Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening. Waqas M; Haider A; Rehman A; Qasim M; Umar A; Sufyan M; Akram HN; Mir A; Razzaq R; Rasool D; Tahir RA; Sehgal SA Biomed Res Int; 2021; 2021():1596834. PubMed ID: 33728324 [TBL] [Abstract][Full Text] [Related]
2. Elucidation of novel compounds and epitope-based peptide vaccine design against C30 endopeptidase regions of SARS-CoV-2 using immunoinformatics approaches. Marriam S; Afghan MS; Nadeem M; Sajid M; Ahsan M; Basit A; Wajid M; Sabri S; Sajid M; Zafar I; Rashid S; Sehgal SA; Alkhalifah DHM; Hozzein WN; Chen KT; Sharma R Front Cell Infect Microbiol; 2023; 13():1134802. PubMed ID: 37293206 [TBL] [Abstract][Full Text] [Related]
3. Epitope-based peptide vaccine design and elucidation of novel compounds against 3C like protein of SARS-CoV-2. Sajid M; Marriam S; Mukhtar H; Sohail S; Sajid M; Sehgal SA PLoS One; 2022; 17(3):e0264700. PubMed ID: 35324925 [TBL] [Abstract][Full Text] [Related]
4. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics. Jakhar R; Kaushik S; Gakhar SK J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348 [TBL] [Abstract][Full Text] [Related]
6. Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics Approaches. Waqas M; Haider A; Sufyan M; Siraj S; Sehgal SA Front Mol Biosci; 2020; 7():227. PubMed ID: 33195402 [TBL] [Abstract][Full Text] [Related]
7. Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches. Tahir Ul Qamar M; Rehman A; Tusleem K; Ashfaq UA; Qasim M; Zhu X; Fatima I; Shahid F; Chen LL PLoS One; 2020; 15(12):e0244176. PubMed ID: 33351863 [TBL] [Abstract][Full Text] [Related]
8. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2. Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663 [TBL] [Abstract][Full Text] [Related]
9. Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An Dar HA; Waheed Y; Najmi MH; Ismail S; Hetta HF; Ali A; Muhammad K J Immunol Res; 2020; 2020():8893483. PubMed ID: 33274246 [TBL] [Abstract][Full Text] [Related]
10. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research. Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143 [TBL] [Abstract][Full Text] [Related]
11. Identification of SARS-CoV-2 CTL epitopes for development of a multivalent subunit vaccine for COVID-19. Rencilin CF; Rosy JC; Mohan M; Coico R; Sundar K Infect Genet Evol; 2021 Apr; 89():104712. PubMed ID: 33422682 [TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis of Indian SARS-CoV-2 genomes to identify T-cell and B-cell epitopes from conserved regions based on immunogenicity and antigenicity. Ghosh N; Sharma N; Saha I; Saha S Int Immunopharmacol; 2021 Feb; 91():107276. PubMed ID: 33385714 [TBL] [Abstract][Full Text] [Related]
13. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches. Dong R; Chu Z; Yu F; Zha Y Front Immunol; 2020; 11():1784. PubMed ID: 32849643 [TBL] [Abstract][Full Text] [Related]
14. Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2. Behmard E; Soleymani B; Najafi A; Barzegari E Sci Rep; 2020 Nov; 10(1):20864. PubMed ID: 33257716 [TBL] [Abstract][Full Text] [Related]
15. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study. Yang Z; Bogdan P; Nazarian S Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations. Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614 [TBL] [Abstract][Full Text] [Related]
17. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2. Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045 [TBL] [Abstract][Full Text] [Related]
18. Engineering receptor-binding domain and heptad repeat domains towards the development of multi-epitopes oral vaccines against SARS-CoV-2 variants. Arshad NF; Nordin FJ; Foong LC; In LLA; Teo MYM PLoS One; 2024; 19(8):e0306111. PubMed ID: 39146295 [TBL] [Abstract][Full Text] [Related]
19. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein. Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022 [TBL] [Abstract][Full Text] [Related]
20. Design of an epitope-based peptide vaccine against the SARS-CoV-2: a vaccine-informatics approach. Alam A; Khan A; Imam N; Siddiqui MF; Waseem M; Malik MZ; Ishrat R Brief Bioinform; 2021 Mar; 22(2):1309-1323. PubMed ID: 33285567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]